Aroa Biosurgery Ltd
ASX:ARX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Remy Cointreau SA
PAR:RCO
|
FR |
|
T
|
Taiwan Chelic Co Ltd
TWSE:4555
|
TW |
|
C
|
Crazy Sports Group Ltd
HKEX:82
|
CN |
|
FriendTimes Inc
HKEX:6820
|
CN |
|
Seven Principles AG
XETRA:T3T1
|
DE |
|
Beijing Wandong Medical Technology Co Ltd
SSE:600055
|
CN |
Aroa Biosurgery Ltd
Inventory
Aroa Biosurgery Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Aroa Biosurgery Ltd
ASX:ARX
|
Inventory
NZ$8.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Pacific Edge Ltd
NZX:PEB
|
Inventory
NZ$1.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
Aroa Biosurgery Ltd
Glance View
Aroa Biosurgery Ltd. engages in the development of products for wound care and soft tissue regeneration. The firm is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. The company designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.
See Also
What is Aroa Biosurgery Ltd's Inventory?
Inventory
8.3m
NZD
Based on the financial report for Mar 31, 2025, Aroa Biosurgery Ltd's Inventory amounts to 8.3m NZD.
What is Aroa Biosurgery Ltd's Inventory growth rate?
Inventory CAGR 5Y
16%
Over the last year, the Inventory growth was 2%. The average annual Inventory growth rates for Aroa Biosurgery Ltd have been 28% over the past three years , 16% over the past five years .
